Boenning & Scattergood’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,000
Closed -$218K 402
2022
Q3
$218K Buy
+16,000
New +$238K 0.04% 340

Other funds holding BCAT

Boenning & Scattergood's BCAT Position: Q4 2022 in Review

Boenning & Scattergood sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2022, closing a stake of 16,000 shares — an estimated $218K sold.

Boenning & Scattergood first reported a position in BCAT in Q3 2022 and held it in 1 quarter. The position peaked at $218K in Q3 2022. 85 funds tracked by Wall St. Rank hold BCAT as of Q4 2022.

  • Boenning & Scattergood reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2022 after selling out during the quarter.
  • Boenning & Scattergood sold 16,000 BlackRock Capital Allocation Term Trust shares in Q4 2022, an estimated $218K.
  • Boenning & Scattergood first reported a position in BlackRock Capital Allocation Term Trust in Q3 2022 and held it in 1 quarter.
  • Boenning & Scattergood's BlackRock Capital Allocation Term Trust position peaked at $218K in Q3 2022.
  • 85 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.